Citation: Dc. Farrugia et al., SINGLE-AGENT INFUSIONAL 5-FLUOROURACIL IS NOT EFFECTIVE 2ND-LINE THERAPY AFTER RALTITREXED (TOMUDEX(R)) IN ADVANCED COLORECTAL-CANCER, European journal of cancer, 34(7), 1998, pp. 987-991
Authors:
FORD HER
FARRUGIA DC
CUNNINGHAM D
MCVICAR D
MCCARTHY K
MITCHELL F
AHERNE GW
JACKMAN AL
DANENBERG K
LENZ HJ
DANENBERG PV
Citation: Her. Ford et al., A PHARMACODYNAMIC STUDY OF RALTITREXED (TOMUDEX(R)) IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - PREDICTORS OF RESPONSE AND TOXICITY, Annals of oncology, 9, 1998, pp. 606-606
Authors:
FARRUGIA DC
NORMAN AR
NICOLSON MC
GORE M
BOLODEOKU EO
WEBB A
CUNNINGHAM D
Citation: Dc. Farrugia et al., UNKNOWN PRIMARY-CARCINOMA - RANDOMIZED STUDIES ARE NEEDED TO IDENTIFYOPTIMAL TREATMENTS AND THEIR BENEFITS, European journal of cancer, 32A(13), 1996, pp. 2256-2261
Authors:
JACKMAN AL
FARRUGIA DC
GIBSON W
KIMBELL R
HARRAP KR
STEPHENS TC
AZAB M
BOYLE FT
Citation: Al. Jackman et al., ZD1694 (TOMUDEX) - A NEW THYMIDYLATE SYNTHASE INHIBITOR WITH ACTIVITYIN COLORECTAL-CANCER, European journal of cancer, 31A(7-8), 1995, pp. 1277-1282